Clinical Trial Update: Simvastatin Effect on the Incidence of Acute Lung Injury/Adult Respiratory Distress Syndrome (ALI/ARDS) [NA]

View source ↗

Summary

A clinical trial investigating whether simvastatin affects the incidence of acute lung injury and acute respiratory distress syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Injury
• Respiratory Distress Syndrome

Drugs mentioned

• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: University of Oklahoma | Conditions: Adult Respiratory Distress Syndrome, Acute Lung Injury | NA | Status: WITHDRAWN